[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-403879-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-403879-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prep-and-its-delivery-experience-in-asia","PrEP and Its Delivery Experience in Asia","","This document outlines clinical perspectives and delivery experiences regarding Pre-Exposure Prophylaxis (PrEP) as a critical tool for HIV prevention in Asia. It addresses the efficacy of PrEP, potential clinical considerations, and practical implementation strategies, including insights from the NUH BEPREP Clinic. The content evaluates the limitations of traditional prevention methods, such as inconsistent condom usage, against the backdrop of UN Millennium Goals aiming to end the HIV epidemic by 2030 through viral suppression and expanded preventative interventions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prep-and-its-delivery-experience-in-asia/403879/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prep-and-its-delivery-experience-in-asia/403879.png","ImageObject",300,407,{"name":42,"@type":43},"aboduw","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-27",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are the primary goals for HIV prevention by 2030?","Question",{"text":63,"@type":64},"The U.N. Millennium Goals target 73% viral suppression among people living with HIV by 2020, with the objective of ending the HIV epidemic by 2030 through these intensified efforts.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What challenges are associated with the traditional use of condoms for HIV prevention?",{"text":68,"@type":64},"While condoms are a long-standing and effective tool for protecting against HIV and STIs, efficacy is heavily dependent on consistent and proper use. Data suggests that only 16% of MSM report consistent use, and inconsistent usage provides no significant protection.",{"name":70,"@type":61,"acceptedAnswer":71},"What topics are covered regarding the delivery of PrEP?",{"text":72,"@type":64},"The document discusses PrEP efficacy, necessary clinical precautions, delivery challenges, practical implementation examples within the Asian region, and personal clinical experience from the NUH BEPREP Clinic.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},403879,1791085252,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":94,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},3985747862266,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","PrEP and its delivery experience in Asia  \nDr Dariusz P. Olszyna, MD, PhD, FAMS National University Health Systems  \nSingapore  \n17 February 2017  \nWhat’s on the menu today:  \n• PrEP efficacy  \n• PrEP – caution advised?  \n• Clinical aspects of PrEP delivery  \n• Examples of PrEP implementation in Asia  \n• PrEP implementation – personal experience  \n• NUH BEPREP Clinic  \nIntroduction  \n…gaining momentum with PrEP  \nU.N. Millennium Goals  \n(by 2020)  \nU.N. Millennium Goals  \nWhat do they mean?  \n• 73% PLHIVs worldwide will be virally suppressed (2- 3 fold increase from current state)  \n• modelling suggests that this will end HIV epidemic by 2030  \nIn spite of years of HIV prevention  \n4 people infected with HIV every minute!  \n3 people dying from HIV every minute!  \n300,000 new infections in Asia-Pacific region in 2016  \nCondoms  \n…the old mantra of HIV prevention  \n􀀹 Longest known HIV prevention tool with a good record  \n􀀹 It has averted millions of infections  \n􀀹 Protect from HIV and other STIs  \n, but…  \nCondoms efficacy  \n•  only 16% of the MSM reported consistent condom use during anal intercourse with male partner of any HIV status over the entire observation period  \n• 70% effectiveness when condoms used consistently (compared with never use)  \n• no protection when comparing sometimes use to never  \nCondoms  \n…the old mantra of HIV prevention  \n􀀹 Longest known HIV prevention tool with a good record  \n􀀹 It has averted millions of infections  \n􀀹 Protect from HIV and other STIs  \nbut  \n• Condoms are an effective tool in HIV prevention  \n• Consistent and proper use are key","cbCaiulj9feh7Jxd","https://ap.wps.com/l/cbCaiulj9feh7Jxd","pdf",6635185,"English","# PrEP Overview and Efficacy\n## Clinical Delivery Aspects\n# Implementation in Asia\n## NUH BEPREP Clinic Case Study","[{\"question\":\"What are the primary goals for HIV prevention by 2030?\",\"answer\":\"The U.N. Millennium Goals target 73% viral suppression among people living with HIV by 2020, with the objective of ending the HIV epidemic by 2030 through these intensified efforts.\"},{\"question\":\"What challenges are associated with the traditional use of condoms for HIV prevention?\",\"answer\":\"While condoms are a long-standing and effective tool for protecting against HIV and STIs, efficacy is heavily dependent on consistent and proper use. Data suggests that only 16% of MSM report consistent use, and inconsistent usage provides no significant protection.\"},{\"question\":\"What topics are covered regarding the delivery of PrEP?\",\"answer\":\"The document discusses PrEP efficacy, necessary clinical precautions, delivery challenges, practical implementation examples within the Asian region, and personal clinical experience from the NUH BEPREP Clinic.\"}]","PrEP and Its Delivery Experience in Asia | PDF",1790544336,176]